We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Biological Implants MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

In this report, the global Biological Implants market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

The biological implant is referred to as prosthesis that is compatible with cells and tissues, resist cell adhesion, and protein deposition. They are widely used in the reconstructive procedures for restoring the organs and tissues. Autografts, allografts, and xenografts are some of the types of biological implants. They find application in cardiovascular implants, orthopedic implants, and other soft tissue implants. Biological implants can be placed through surgical and injectable mode.

Increasing penetration of biological implants coupled with the advancement in biological implants is a prime factor expected to propel the market growth. For instance, in March 2019, Nobel Biocare launched Xeal and TiUltra surfaces at the International Dental Show (IDS) in Cologne. This product is not only applicable to implants but also abutments, these new surfaces were created to optimize tissue integration at every level for the purpose of improved implant treatment outcomes.

The emergence of the regenerative medicine industry which uses various therapeutic approaches for targeting the main cause of the disease is further expected to propel the market growth of biological implants. For instance, in Feburary 2019, FDA issued final guidance on the development of regenerative medicine therapies such as cell or tissue products, saying the treatments have the potential to address "hundreds of vexing human diseases and conditions."

From the geographical perspective, North America is projected to exhibit significant growth over the forecast period and this can be attributed to the presence of well-established healthcare infrastructure and rising approval of novel biological implants by the FDA in the region. For instance, in May 2019, OSSIO, Inc., an orthopedic fixation company, announced the U.S. launch and first commercial use of the OSSIOfiberTM Bone Pin Family for maintenance of alignment and fixation of bone fractures, osteotomies, arthrodesis, and bone grafts.

On the flip side, the high production cost of the biological implants is expected to hamper the market growth.

Key Developments:

• In April 2017, CAMLOG Biotechnologies AG and BioHorizons, Inc., two providers of dental implants and products for restorative dentistry, announced that CAMLOG Vertriebs GmbH will become the exclusive distributor of BioHorizons-branded products in Germany. CAMLOG will continue to offer customers a selection of implant-based treatment solutions as an exclusive German distributor.

• In Mar 2019, Mirus has received FDA 510(k) approval for the MoRe® based Europa™ Pedicle Screw System making it the first FDA approved medical device with this new class of implant material.

• In May 2019, Alphatec Holdings, Inc. a medical device company announced the commercial release of its IdentiTi-PC Porous Titanium Interbody Implant System for Transforaminal Lumbar Interbody Fusion Procedures (TLIF).

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biological Implants in these regions, from 2014 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Biological Implants market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Integra LifeSciences Corporation
NuVasive, Inc
Edward LifeSciences Corporation
Stryker Corporation
LifeCell corporation
Medtronic
RTI Surgical, Inc
BioPolymer GmbH & Co. KG
Johnson & Johnson
Baxter International, Inc.
Vericel Corporation
Alphatec Spine, Inc
CryoLife
Maxigen Biotech, Inc.
IOP Ophthalmic Products, Inc.
CONMED
Allergan Plc
BioTissue
Auto Tissue Berlin GmbH
MiMedx Group, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Autografts
Allografts
Xenografts

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Biological Implants for each application, including
Cardiovascular Implants
Orthopedic Implants
Dental Implants
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Biological Implants Market Research Report 2019
1 Biological Implants Market Overview
1.1 Product Overview and Scope of Biological Implants
1.2 Biological Implants Segment by Type (Product Category)
1.2.1 Global Biological Implants Production and CAGR (%) Comparison by Type (Product Category)(2014-2025)
1.2.2 Global Biological Implants Production Market Share by Type (Product Category) in 2018
1.2.3 Autografts
1.2.4 Allografts
1.2.5 Xenografts
1.3 Global Biological Implants Segment by Application
1.3.1 Biological Implants Consumption (Sales) Comparison by Application (2014-2025)
1.3.2 Cardiovascular Implants
1.3.3 Orthopedic Implants
1.3.4 Dental Implants
1.3.5 Other
1.4 Global Biological Implants Market by Region (2014-2025)
1.4.1 Global Biological Implants Market Size (Value) and CAGR (%) Comparison by Region (2014-2025)
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.4.6 Southeast Asia Status and Prospect (2014-2025)
1.4.7 India Status and Prospect (2014-2025)
1.5 Global Market Size (Value) of Biological Implants (2014-2025)
1.5.1 Global Biological Implants Revenue Status and Outlook (2014-2025)
1.5.2 Global Biological Implants Capacity, Production Status and Outlook (2014-2025)

2 Global Biological Implants Market Competition by Manufacturers
2.1 Global Biological Implants Capacity, Production and Share by Manufacturers (2014-2019)
2.1.1 Global Biological Implants Capacity and Share by Manufacturers (2014-2019)
2.1.2 Global Biological Implants Production and Share by Manufacturers (2014-2019)
2.2 Global Biological Implants Revenue and Share by Manufacturers (2014-2019)
2.3 Global Biological Implants Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Biological Implants Manufacturing Base Distribution, Sales Area and Product Type
2.5 Biological Implants Market Competitive Situation and Trends
2.5.1 Biological Implants Market Concentration Rate
2.5.2 Biological Implants Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Biological Implants Capacity, Production, Revenue (Value) by Region (2014-2019)
3.1 Global Biological Implants Capacity and Market Share by Region (2014-2019)
3.2 Global Biological Implants Production and Market Share by Region (2014-2019)
3.3 Global Biological Implants Revenue (Value) and Market Share by Region (2014-2019)
3.4 Global Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.5 North America Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.6 Europe Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.7 China Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.8 Japan Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.9 Southeast Asia Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.10 India Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Biological Implants Supply (Production), Consumption, Export, Import by Region (2014-2019)
4.1 Global Biological Implants Consumption by Region (2014-2019)
4.2 North America Biological Implants Production, Consumption, Export, Import (2014-2019)
4.3 Europe Biological Implants Production, Consumption, Export, Import (2014-2019)
4.4 China Biological Implants Production, Consumption, Export, Import (2014-2019)
4.5 Japan Biological Implants Production, Consumption, Export, Import (2014-2019)
4.6 Southeast Asia Biological Implants Production, Consumption, Export, Import (2014-2019)
4.7 India Biological Implants Production, Consumption, Export, Import (2014-2019)

5 Global Biological Implants Production, Revenue (Value), Price Trend by Type
5.1 Global Biological Implants Production and Market Share by Type (2014-2019)
5.2 Global Biological Implants Revenue and Market Share by Type (2014-2019)
5.3 Global Biological Implants Price by Type (2014-2019)
5.4 Global Biological Implants Production Growth by Type (2014-2019)

6 Global Biological Implants Market Analysis by Application
6.1 Global Biological Implants Consumption and Market Share by Application (2014-2019)
6.2 Global Biological Implants Consumption Growth Rate by Application (2014-2019)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Biological Implants Manufacturers Profiles/Analysis
7.1 Integra LifeSciences Corporation
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Biological Implants Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Integra LifeSciences Corporation Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business/Business Overview
7.2 NuVasive, Inc
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Biological Implants Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 NuVasive, Inc Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business/Business Overview
7.3 Edward LifeSciences Corporation
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Biological Implants Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Edward LifeSciences Corporation Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business/Business Overview
7.4 Stryker Corporation
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Biological Implants Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Stryker Corporation Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business/Business Overview
7.5 LifeCell corporation
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Biological Implants Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 LifeCell corporation Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business/Business Overview
7.6 Medtronic
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Biological Implants Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Medtronic Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business/Business Overview
7.7 RTI Surgical, Inc
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Biological Implants Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 RTI Surgical, Inc Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business/Business Overview
7.8 BioPolymer GmbH & Co. KG
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Biological Implants Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 BioPolymer GmbH & Co. KG Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business/Business Overview
7.9 Johnson & Johnson
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Biological Implants Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Johnson & Johnson Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business/Business Overview
7.10 Baxter International, Inc.
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Biological Implants Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Baxter International, Inc. Biological Implants Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business/Business Overview
7.11 Vericel Corporation
7.12 Alphatec Spine, Inc
7.13 CryoLife
7.14 Maxigen Biotech, Inc.
7.15 IOP Ophthalmic Products, Inc.
7.16 CONMED
7.17 Allergan Plc
7.18 BioTissue
7.19 Auto Tissue Berlin GmbH
7.20 MiMedx Group, Inc.

8 Biological Implants Manufacturing Cost Analysis
8.1 Biological Implants Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biological Implants

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Biological Implants Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biological Implants Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Biological Implants Market Forecast (2019-2025)
12.1 Global Biological Implants Capacity, Production, Revenue Forecast (2019-2025)
12.1.1 Global Biological Implants Capacity, Production and Growth Rate Forecast (2019-2025)
12.1.2 Global Biological Implants Revenue and Growth Rate Forecast (2019-2025)
12.1.3 Global Biological Implants Price and Trend Forecast (2019-2025)
12.2 Global Biological Implants Production, Consumption , Import and Export Forecast by Region (2019-2025)
12.2.1 North America Biological Implants Production, Revenue, Consumption, Export and Import Forecast (2019-2025)
12.2.2 Europe Biological Implants Production, Revenue, Consumption, Export and Import Forecast (2019-2025)
12.2.3 China Biological Implants Production, Revenue, Consumption, Export and Import Forecast (2019-2025)
12.2.4 Japan Biological Implants Production, Revenue, Consumption, Export and Import Forecast (2019-2025)
12.2.5 Southeast Asia Biological Implants Production, Revenue, Consumption, Export and Import Forecast (2019-2025)
12.2.6 India Biological Implants Production, Revenue, Consumption, Export and Import Forecast (2019-2025)
12.3 Global Biological Implants Production, Revenue and Price Forecast by Type (2019-2025)
12.4 Global Biological Implants Consumption Forecast by Application (2019-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.